N-(tert-butyl)-2-methylbutanamide | 29138-69-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: N-(tert-butyl)-2-methylbutanamide
• 英文别名: N-tert-butyl-2-methylbutanamide
• CAS: 29138-69-0
• 化学式: C₉H₁₉NO
• 分子量: 157.256
• InChiKey: HVWOSCHYESMJNP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  (E)-2-(tert-butylamino)-3-methylpent-2-enenitrile 生成 N-(tert-butyl)-2-methylbutanamide
  参考文献：
  名称：

  KIMPE N. DE; VERHE R.; BUYCK L. DE; CHYS J.; SCHAMP N., J. ORG. CHEM., 1978, 43, NO 13, 2670-2672

  摘要：

  DOI：

文献信息

• Nickel-Catalyzed Formal Aminocarbonylation of Unactivated Alkyl Iodides with Isocyanides
  作者：Wenyi Huang、Yun Wang、Yangyang Weng、Mohini Shrestha、Jingping Qu、Yifeng Chen

  DOI：10.1021/acs.orglett.0c01022

  日期：2020.4.17

  iodides with isocyanides to afford alkyl amide, which proceeds via the selective monomigratory insertion of isocyanides with alkyl iodides, subsequent β-hydride elimination, and hydrolysis process. The reaction features wide functional group tolerance under mild conditions. Additionally, the selective, one-pot hydrolysis of reaction mixture under acid conditions allows for expedient synthesis of the corresponding

  在本文中，我们公开了伯和仲未活化的脂肪族碘与异氰的镍催化的正式氨基羰基化反应，以提供烷基酰胺，其通过异氰与烷基碘的选择性单迁移插入，随后的β-氢化物消除和水解过程而进行。该反应在温和条件下具有宽泛的官能团耐受性。另外，在酸性条件下反应混合物的选择性的一锅水解允许方便地合成相应的烷基羧酸。
• [EN] PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE LA PIPÉRIDINONE EN TANT QU'INHIBITEURS DE MDM2 POUR LE TRAITEMENT DU CANCER
  申请人：AMGEN INC

  公开号：WO2011153509A1

  公开（公告）日：2011-12-08

  The present invention provides MDM2 inhibitor compounds of Formula (I), wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.

  本发明提供了式（I）的MDM2抑制剂化合物，其中变量如上所定义，这些化合物可用作治疗剂，特别是用于癌症的治疗。本发明还涉及含有MDM2抑制剂的药物组合物。
• COSMETIC COMPOSITION COMPRISING AT LEAST ONE CATIONIC COPOLYMER AND AT LEAST ONE ANIONIC ASSOCIATIVE POLYMER AND COSMETIC TREATMENT PROCESSES USING SAID COMPOSITION
  申请人：BIGANSKA Olga

  公开号：US20090074692A1

  公开（公告）日：2009-03-19

  The disclosure relates to novel cosmetic compositions comprising, in a cosmetically acceptable medium: (i) at least one cationic polymer which are produced by polymerization of a mixture of monomers comprising: a) at least one vinyl monomer substituted with at least one amino group, b) at least one hydrophobic nonionic vinyl monomer, c) at least one associative vinyl monomer, and e) at least one hydroxylated nonionic vinyl monomer, and (ii) at least one anionic associative polymers.

  该披露涉及新型化妆品组合物，包括在适合用于化妆的介质中的：(i) 至少一种阳离子聚合物，其由包括：a) 至少一种含有至少一个氨基团的乙烯单体，b) 至少一种疏水非离子乙烯单体，c) 至少一种关联性乙烯单体，和e) 至少一种羟基化非离子乙烯单体的单体混合物聚合而成，以及(ii) 至少一种阴离子关联性聚合物。
• COMPOUNDS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADENOSINE A2A RECEPTOR
  申请人：Corvus Pharmaceuticals, Inc.

  公开号：EP3616753A1

  公开（公告）日：2020-03-04

  Disclosed herein, inter alia, are compounds of formula (I) and their use in methods for modulating Adenosine Receptors.

  本公开的内容包括式(I)的化合物及其在调节腺苷受体的方法中的应用。
• COSMETIC AND/OR DERMATOLOGICAL COMPOSITION BASED ON N,N'-DIARYLMETHYLENEETHYLENEDIAMINEDIACETIC ACID ESTER(S)
  申请人：KERMORVAN Cecile

  公开号：US20100254922A1

  公开（公告）日：2010-10-07

  The present invention relates to a cosmetic and/or dermatological composition comprising, in a physiologically acceptable medium containing at least one oil: (a) at least one compound of general formula (Ia): and (b) an efficient amount of at least one solvent chosen from: (i) isononyl isononanoate; (ii) dimethyl isosorbide; (iii) the amino acid esters of formula (II): R′ 1 (CO)N(R′ 2 )CH(R′ 3 )(CH 2 ) n (CO)OR′ 4 (II) (iv) and a mixture thereof.

  本发明涉及一种化妆品和/或皮肤科学组合物，其包括在至少含有一种油的生理上可接受的介质中：(a)至少一种通式(Ia)的化合物；和(b)来自以下至少一种溶剂的有效量：(i)异辛酸异壬酯；(ii)二甲基异山梨醇酯；(iii)通式(II)的氨基酸酯：R′1(CO)N(R′2)CH(R′3)(CH2)n(CO)OR′4；(iv)和其混合物。